The fibrinogen C-terminal domain is seldom C-mannosylated but its C-mannosylation is important for the secretion of microfibril-associated glycoprotein 4.


Journal

Biochimica et biophysica acta. General subjects
ISSN: 1872-8006
Titre abrégé: Biochim Biophys Acta Gen Subj
Pays: Netherlands
ID NLM: 101731726

Informations de publication

Date de publication:
09 2020
Historique:
received: 07 10 2019
revised: 13 05 2020
accepted: 16 05 2020
pubmed: 23 5 2020
medline: 15 12 2020
entrez: 23 5 2020
Statut: ppublish

Résumé

C-mannosylation is the one of glycosylations. Microfibril-associated glycoprotein 4 (MFAP4), an important protein for tissue homeostasis and cell adhesion, contains a consensus sequence of C-mannosylation in its fibrinogen C-terminal domain. In this study, we sought to demonstrate that fibrinogen C-terminal domain is a new substrate domain for C-mannosylation. We established an MFAP4-overexpresssing HT1080 cell line and purified recombinant MFAP4 protein from the conditioned medium for LC-MS/MS analysis. Subcellular localization of MFAP4 was observed under confocal fluorescence microscope. We found that MFAP4 is C-mannosylated at Trp Our results demonstrate that the fibrinogen C-terminal domain is a novel C-mannosylation domain and that the C-mannosylation of MFAP4 is important for its secretion. These results suggest that C-mannosylation has a role for dominant effect for MFAP4 secretion.

Sections du résumé

BACKGROUND
C-mannosylation is the one of glycosylations. Microfibril-associated glycoprotein 4 (MFAP4), an important protein for tissue homeostasis and cell adhesion, contains a consensus sequence of C-mannosylation in its fibrinogen C-terminal domain. In this study, we sought to demonstrate that fibrinogen C-terminal domain is a new substrate domain for C-mannosylation.
METHODS
We established an MFAP4-overexpresssing HT1080 cell line and purified recombinant MFAP4 protein from the conditioned medium for LC-MS/MS analysis. Subcellular localization of MFAP4 was observed under confocal fluorescence microscope.
RESULTS
We found that MFAP4 is C-mannosylated at Trp
CONCLUSIONS
Our results demonstrate that the fibrinogen C-terminal domain is a novel C-mannosylation domain and that the C-mannosylation of MFAP4 is important for its secretion.
GENERAL SIGNIFICANCE
These results suggest that C-mannosylation has a role for dominant effect for MFAP4 secretion.

Identifiants

pubmed: 32442478
pii: S0304-4165(20)30149-5
doi: 10.1016/j.bbagen.2020.129637
pii:
doi:

Substances chimiques

Carrier Proteins 0
Extracellular Matrix Proteins 0
Glycoproteins 0
MFAP4 protein, human 0
Fibrinogen 9001-32-5
Mannose PHA4727WTP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

129637

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflict of interest to declare.

Auteurs

Yoshiyuki Osada (Y)

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 223-8522, Japan.

Takehiro Suzuki (T)

Biomolecular Characterization Unit, RIKEN Center for Sustainable Resource Science Wako, 351-0198, Japan.

Hayato Mizuta (H)

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 223-8522, Japan.

Kento Mori (K)

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 223-8522, Japan.

Kazuki Miura (K)

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 223-8522, Japan.

Naoshi Dohmae (N)

Biomolecular Characterization Unit, RIKEN Center for Sustainable Resource Science Wako, 351-0198, Japan.

Siro Simizu (S)

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 223-8522, Japan. Electronic address: simizu@applc.keio.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH